Natera strikes deal in Hong Kong for prenatal test

12/17/2013 | GenomeWeb Daily News (free registration)

Natera has entered into a distribution deal with DiagCor for undisclosed terms. The deal calls for DiagCor to introduce Natera's Panorama prenatal test in Hong Kong. The blood-based assay is used for the noninvasive detection of trisomy 13, 18 and 21, as well as sex chromosome aneuploidies, triploidy and monosomy X.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY